Cargando…

A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris

BACKGROUND: Keratosis pilaris (KP) is a keratinization disorder that is characterized by follicular hyperkeratosis, with surrounding erythema. Topical treatments are widely used, but their effects are limited. OBJECTIVE: To evaluate the effectiveness of the Q-switched 1064-nm Nd:YAG laser for the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Juhee, Kim, Beom Joon, Kim, Myeung Nam, Lee, Chang Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162257/
https://www.ncbi.nlm.nih.gov/pubmed/21909198
http://dx.doi.org/10.5021/ad.2011.23.3.293
_version_ 1782210799566061568
author Park, Juhee
Kim, Beom Joon
Kim, Myeung Nam
Lee, Chang Kyun
author_facet Park, Juhee
Kim, Beom Joon
Kim, Myeung Nam
Lee, Chang Kyun
author_sort Park, Juhee
collection PubMed
description BACKGROUND: Keratosis pilaris (KP) is a keratinization disorder that is characterized by follicular hyperkeratosis, with surrounding erythema. Topical treatments are widely used, but their effects are limited. OBJECTIVE: To evaluate the effectiveness of the Q-switched 1064-nm Nd:YAG laser for the treatment of KP. METHODS: Total of 12 patients with KP were treated with a Q-switched 1064-nm Nd:YAG laser. Ten sessions of laser treatment were delivered once every two weeks. The entire lesions were treated with the following laser settings: 4.0~5.0 J/cm(2), 4-mm spot size, and three passes. Two dermatologists' clinical evaluations and patients' satisfaction were assessed between before treatment (baseline) and at 1 month after the last treatment. RESULTS: Eleven of the twelve patients showed more than grade 2 (>25%) improvement in texture and dyspigmentation in KP lesions, respectively. A half of the patients (50%) showed more than 50% improvement in the skin texture. Regarding dyspigmentation, five patients (41.7%) showed more than 50% improvement. Eleven out of twelve participants were satisfied (>25% of the Patients' self assessment) with the procedure. No significant adverse effect was observed. CONCLUSION: Although the Q-switched 1064-nm laser treatment may not be the first line therapy for KP, it might be a new treatment option for the patients with recalcitrant KP.
format Online
Article
Text
id pubmed-3162257
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-31622572011-09-09 A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris Park, Juhee Kim, Beom Joon Kim, Myeung Nam Lee, Chang Kyun Ann Dermatol Original Article BACKGROUND: Keratosis pilaris (KP) is a keratinization disorder that is characterized by follicular hyperkeratosis, with surrounding erythema. Topical treatments are widely used, but their effects are limited. OBJECTIVE: To evaluate the effectiveness of the Q-switched 1064-nm Nd:YAG laser for the treatment of KP. METHODS: Total of 12 patients with KP were treated with a Q-switched 1064-nm Nd:YAG laser. Ten sessions of laser treatment were delivered once every two weeks. The entire lesions were treated with the following laser settings: 4.0~5.0 J/cm(2), 4-mm spot size, and three passes. Two dermatologists' clinical evaluations and patients' satisfaction were assessed between before treatment (baseline) and at 1 month after the last treatment. RESULTS: Eleven of the twelve patients showed more than grade 2 (>25%) improvement in texture and dyspigmentation in KP lesions, respectively. A half of the patients (50%) showed more than 50% improvement in the skin texture. Regarding dyspigmentation, five patients (41.7%) showed more than 50% improvement. Eleven out of twelve participants were satisfied (>25% of the Patients' self assessment) with the procedure. No significant adverse effect was observed. CONCLUSION: Although the Q-switched 1064-nm laser treatment may not be the first line therapy for KP, it might be a new treatment option for the patients with recalcitrant KP. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011-08 2011-08-06 /pmc/articles/PMC3162257/ /pubmed/21909198 http://dx.doi.org/10.5021/ad.2011.23.3.293 Text en Copyright © 2011 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, Juhee
Kim, Beom Joon
Kim, Myeung Nam
Lee, Chang Kyun
A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris
title A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris
title_full A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris
title_fullStr A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris
title_full_unstemmed A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris
title_short A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris
title_sort pilot study of q-switched 1064-nm nd:yag laser treatment in the keratosis pilaris
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162257/
https://www.ncbi.nlm.nih.gov/pubmed/21909198
http://dx.doi.org/10.5021/ad.2011.23.3.293
work_keys_str_mv AT parkjuhee apilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris
AT kimbeomjoon apilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris
AT kimmyeungnam apilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris
AT leechangkyun apilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris
AT parkjuhee pilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris
AT kimbeomjoon pilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris
AT kimmyeungnam pilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris
AT leechangkyun pilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris